The International HapMap Project is a partnership of scientists and funding agencies from Canada, China, Japan, Nigeria, UK and US to develop a public resource to help researchers find genes associated with human disease and find responses to pharmaceuticals.
The Project’s goal is to compare the genetic sequences of different individuals to identify chromosomal regions where genetic variants are shared. By making this information freely available, the Project will help biomedical researchers find genes involved in disease and responses to therapeutic drugs. In the initial Project phase, genetic data is being gathered from four populations with African, Asian, and European ancestry. Ongoing interactions with members of these populations are addressing potential ethical issues and providing valuable experience in conducting research with identified populations.
URL:
Collaborators:
Japan:
RIKEN and University of Tokyo; Health Sciences University of Hokkaido with Eubios Ethics Institute
UK:
Wellcome Trust Sanger Institute; University of Oxford; University of Oxford/Wellcome Trust Centre for Human Genetics
Canada:
McGill University and Génome Québec Innovation Centre
China:
The Chinese HapMap Consortium (Beijing Genomics Institute, Chinese National Human Genome Center at Beijing, University of Hong Kong, Hong Kong University of Science and Technology, The Chinese University of Hong Kong, Chinese National Human Genome Center at Shanghai); Beijing Normal University; Beijing Genomics Institute
USA:
Illumina; Broad Institute of Harvard and MIT; Baylor College of Medicine with ParAllele Bioscience; University of California, San Francisco with Washington University in St. Louis; Perlegen Sciences; Johns Hopkins School of Medicine; University of Utah; Cold Spring Harbor Laboratory; Howard University
Nigeria:
University of Ibadan
